COMMD6

COMMD6 is a COMM domain-containing protein that operates within the COMMD/CCDC22/CCDC93 (CCC) complex to control endosomal recycling of cell surface receptors (PMID:29545368). It directly binds COMMD1 and, through the broader COMMD family, is required for the structural integrity of the entire COMMD protein family and the core CCC complex: hepatic Commd6 loss collapses the protein levels of all ten COMMD members and destabilizes CCDC22, CCDC93, and C16orf62 (PMID:16573520, PMID:29545368). This destabilization reduces cell-surface LDLR and LRP1, producing elevated plasma LDL cholesterol, and impairs ATP7B-dependent copper handling, causing hepatic copper accumulation under high-copper conditions (PMID:29545368, PMID:33262129). Independently of its trafficking role, COMMD6 inhibits TNF-induced NF-κB activation through a mechanism requiring COMM domain residues Trp24 and Pro41; unlike COMMD1, it does not bind IκBα, marking an overlapping but mechanistically distinct route of NF-κB suppression (PMID:16573520).

1. 2006 High

   Established COMMD6 as a direct COMMD1-interacting NF-κB regulator and mapped the COMM domain residues required for its inhibitory activity, defining its functional autonomy from COMMD1.

   Evidence Endogenous reciprocal co-immunoprecipitation, COMM domain site-directed mutagenesis (Trp24, Pro41), and NF-κB reporter assays under TNF stimulation

   PMID:16573520

   Open questions at the time

   • Does not identify the molecular target through which COMMD6 suppresses NF-κB, since it does not bind IκBα
   • No structural basis for the Trp24/Pro41 requirement
2. 2018 High

   Demonstrated in vivo that COMMD6 is required for COMMD family and CCC complex stability and for LDLR-mediated cholesterol homeostasis, placing it at the core of endosomal receptor recycling.

   Evidence Liver-specific Commd6 knockout mice with targeted proteomics, biochemical fractionation, cell-surface receptor and plasma cholesterol measurement

   PMID:29545368

   Open questions at the time

   • Does not resolve how COMMD6 is incorporated into or stabilizes the CCC complex mechanistically
   • Whether NF-κB regulation and CCC stabilization are coupled functions is not addressed
3. 2021 High

   Extended COMMD6's CCC-dependent role to copper metabolism, showing hepatic but not enterocyte COMMD6 loss disrupts ATP7B-dependent copper handling.

   Evidence Tissue-specific Commd6/Commd1/Commd9 knockout mice with copper measurement under defined dietary copper and biochemical CCC stability assays

   PMID:33262129

   Open questions at the time

   • Direct interaction between the CCC complex and ATP7B not demonstrated
   • Tissue-specific basis for enterocyte versus hepatocyte difference unexplained
4. 2009 Medium

   Characterized an invertebrate COMMD6 ortholog as a creatine kinase-binding inhibitor, indicating a possible CCC-independent biochemical activity, though in a non-mammalian system.

   Evidence Reciprocal pull-down and creatine kinase enzymatic activity assays with recombinant amphioxus BbCOMMD6 and subcellular fractionation

   PMID:19638315

   Open questions at the time

   • Non-mammalian ortholog; relevance to human COMMD6 not established
   • Single lab, not independently confirmed
   • Functional consequence of creatine kinase inhibition in vivo unknown

• How COMMD6 stabilizes the CCC complex at the molecular level and how its NF-κB-inhibitory function relates to its endosomal trafficking role remain unresolved.
• No structural model of COMMD6 within the CCC complex
• Mechanism linking COMM domain residues to NF-κB inhibition undefined
• Direct molecular target of NF-κB suppression unidentified